CONTEXT: Sleep disturbance is a problem for oncology patients. OBJECTIVES: To evaluate how sleep disturbance and daytime sleepiness (DS) changed from before to six months following surgery and whether certain characteristics predicted initial levels and/or the trajectories of these parameters. METHODS: Patients (n=396) were enrolled prior to surgery and completed monthly assessments for six months following surgery. The General Sleep Disturbance Scale was used to assess sleep disturbance and DS. Using hierarchical linear modeling, demographic, clinical, symptom, and psychosocial adjustment characteristics were evaluated as predictors of initial levels and trajectories of sleep disturbance and DS. RESULTS: All seven General Sleep Disturbance Scale scores were above the cutoff for clinically meaningful levels of sleep disturbance. Lower performance status; higher comorbidity, attentional fatigue, and physical fatigue; and more severe hot flashes predicted higher preoperative levels of sleep disturbance. Higher levels of education predicted higher sleep disturbance scores over time. Higher levels of depressive symptoms predicted higher preoperative levels of sleep disturbance, which declined over time. Lower performance status; higher body mass index; higher fear of future diagnostic tests; not having had sentinel lymph node biopsy; having had an axillary lymph node dissection; and higher depression, physical fatigue, and attentional fatigue predicted higher DS prior to surgery. Higher levels of education, not working for pay, and not having undergone neo-adjuvant chemotherapy predicted higher DS scores over time. CONCLUSION: Sleep disturbance is a persistent problem for patients with breast cancer. The effects of interventions that can address modifiable risk factors need to be evaluated.
CONTEXT: Sleep disturbance is a problem for oncology patients. OBJECTIVES: To evaluate how sleep disturbance and daytime sleepiness (DS) changed from before to six months following surgery and whether certain characteristics predicted initial levels and/or the trajectories of these parameters. METHODS:Patients (n=396) were enrolled prior to surgery and completed monthly assessments for six months following surgery. The General Sleep Disturbance Scale was used to assess sleep disturbance and DS. Using hierarchical linear modeling, demographic, clinical, symptom, and psychosocial adjustment characteristics were evaluated as predictors of initial levels and trajectories of sleep disturbance and DS. RESULTS: All seven General Sleep Disturbance Scale scores were above the cutoff for clinically meaningful levels of sleep disturbance. Lower performance status; higher comorbidity, attentional fatigue, and physical fatigue; and more severe hot flashes predicted higher preoperative levels of sleep disturbance. Higher levels of education predicted higher sleep disturbance scores over time. Higher levels of depressive symptoms predicted higher preoperative levels of sleep disturbance, which declined over time. Lower performance status; higher body mass index; higher fear of future diagnostic tests; not having had sentinel lymph node biopsy; having had an axillary lymph node dissection; and higher depression, physical fatigue, and attentional fatigue predicted higher DS prior to surgery. Higher levels of education, not working for pay, and not having undergone neo-adjuvant chemotherapy predicted higher DS scores over time. CONCLUSION:Sleep disturbance is a persistent problem for patients with breast cancer. The effects of interventions that can address modifiable risk factors need to be evaluated.
Authors: Anand Dhruva; Marylin Dodd; Steven M Paul; Bruce A Cooper; Kathryn Lee; Claudia West; Bradley E Aouizerat; Patrick S Swift; William Wara; Christine Miaskowski Journal: Cancer Nurs Date: 2010 May-Jun Impact factor: 2.592
Authors: Julie L Otte; Janet S Carpenter; Kathleen M Russell; Silvia Bigatti; Victoria L Champion Journal: J Pain Symptom Manage Date: 2010-01-18 Impact factor: 3.612
Authors: Ann M Berger; Brett R Kuhn; Lynne A Farr; Susanna G Von Essen; Julie Chamberlain; James C Lynch; Sangeeta Agrawal Journal: J Clin Oncol Date: 2009-11-02 Impact factor: 44.544
Authors: Oxana G Palesh; Joseph A Roscoe; Karen M Mustian; Thomas Roth; Josée Savard; Sonia Ancoli-Israel; Charles Heckler; Jason Q Purnell; Michelle C Janelsins; Gary R Morrow Journal: J Clin Oncol Date: 2009-11-23 Impact factor: 44.544
Authors: Sara Vargas; William K Wohlgemuth; Michael H Antoni; Suzanne C Lechner; Heather A Holley; Charles S Carver Journal: Psychooncology Date: 2010-06 Impact factor: 3.894
Authors: Susan L Beck; Ann M Berger; Andrea M Barsevick; Bob Wong; Katie A Stewart; William N Dudley Journal: Support Care Cancer Date: 2009-06-13 Impact factor: 3.603
Authors: Maria Tejada; Carol Viele; Kord M Kober; Bruce A Cooper; Steven M Paul; Laura B Dunn; Marilyn J Hammer; Fay Wright; Yvette P Conley; Jon D Levine; Christine Miaskowski Journal: Sleep Date: 2019-10-09 Impact factor: 5.849
Authors: Marianna Kyranou; Kathleen Puntillo; Laura B Dunn; Bradley E Aouizerat; Steven M Paul; Bruce A Cooper; John Neuhaus; Claudia West; Marylin Dodd; Christine Miaskowski Journal: Cancer Nurs Date: 2014 Nov-Dec Impact factor: 2.592
Authors: C Calderon; A Carmona-Bayonas; R Hernandez; B Castelo; S Varma; O Donnay; D Gomez; P Jimenez-Fonseca Journal: Clin Transl Oncol Date: 2019-02-02 Impact factor: 3.405
Authors: Gayle G Page; Elizabeth J Corwin; Susan G Dorsey; Nancy S Redeker; Donna Jo McCloskey; Joan K Austin; Barbara J Guthrie; Shirley M Moore; Debra Barton; Miyong T Kim; Sharron L Docherty; Drenna Waldrop-Valverde; Donald E Bailey; Rachel F Schiffman; Angela Starkweather; Teresa M Ward; Suzanne Bakken; Kathleen T Hickey; Cynthia L Renn; Patricia Grady Journal: J Nurs Scholarsh Date: 2018-03-25 Impact factor: 3.176
Authors: Sueann Mark; Janine Cataldo; Anand Dhruva; Steven M Paul; Lee-May Chen; Marilyn J Hammer; Jon D Levine; Fay Wright; Michelle Melisko; Kathryn Lee; Yvette P Conley; Christine Miaskowski Journal: Support Care Cancer Date: 2017-03-09 Impact factor: 3.603
Authors: Marianna Kyranou; Kathleen Puntillo; Bradley E Aouizerat; Laura B Dunn; Steven M Paul; Bruce A Cooper; Claudia West; Marylin Dodd; Charles Elboim; Christine Miaskowski Journal: J Appl Biobehav Res Date: 2014-06
Authors: Laura B Dunn; Dale J Langford; Steven M Paul; Molly B Berman; Dianne M Shumay; Kord Kober; John D Merriman; Claudia West; John M Neuhaus; Christine Miaskowski Journal: Support Care Cancer Date: 2014-12-19 Impact factor: 3.603